Influence of Diabetes Mellitus on Cardiac Structure and Function and Response to Therapy with LCZ696 in Heart Failure with Preserved Ejection Fraction

被引:0
|
作者
Vardeny, Orly [1 ]
Skali, Hicham [2 ]
Jhund, Pardeep [2 ]
Claggett, Brian [2 ]
Shah, Amil M. [2 ]
Zile, Michael R. [3 ]
Voors, Adrian A. [4 ]
Pieske, Burkert [5 ]
Packer, Milton [6 ]
Lefkowitz, Martin P. [7 ]
Shi, Victor [7 ]
McMurray, John J. V. [8 ]
Solomon, Scott D. [2 ]
机构
[1] Univ Wisconsin, Madison, WI USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Med Univ S Carolina, Charleston, SC 29425 USA
[4] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
[5] Med Univ Graz, Graz, Austria
[6] UT Southwestern, Dallas, TX USA
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Univ Glasgow, Glasgow, Lanark, Scotland
关键词
D O I
10.1016/j.cardfail.2014.06.114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
096
引用
收藏
页码:S40 / S40
页数:1
相关论文
共 50 条
  • [1] Renal effects of lcz696 in patients with heart failure and preserved ejection fraction: results from paramount
    Voors, A. A.
    Gori, M.
    Liu, C. Y. L.
    Zile, M.
    Pieske, B.
    Mc Murray, J. J. V.
    Packer, M.
    Bransford, T.
    Lefkowitz, M.
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 668 - 668
  • [2] Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
    Voors, Adriaan A.
    Gori, Mauro
    Liu, Licette C. Y.
    Claggett, Brian
    Zile, Michael R.
    Pieske, Burkert
    McMurray, John J. V.
    Packer, Milton
    Shi, Victor
    Lefkowitz, Martin P.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (05) : 510 - 517
  • [3] A patient with symptomatic heart failure with preserved left ventricular ejection fraction and right sided heart failure treated with LCZ696
    Cafka, M.
    Xhanaj, J.
    Zace, E.
    Duka, A.
    Seiti, J.
    Balla, I.
    Goda, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 347 - 347
  • [4] LCZ696 vs. enalapril in heart failure patients with reduced ejection fraction
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (06) : 634 - 634
  • [5] Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction
    Ortega-Paz, Luis
    Cristobal, Helena
    Tomas Ortiz-Perez, Jose
    Garcia de Frutos, Pablo
    Mendieta, Guiomar
    Sandoval, Elena
    Jose Rodriguez, Juan
    Ortega, Emilio
    Garcia-Alvarez, Ana
    Brugaletta, Salvatore
    Sabate, Manel
    Paula Dantas, Ana
    ESC HEART FAILURE, 2023, 10 (01): : 453 - 464
  • [6] The Angiotensin Receptor Neprilysin Inhibitor LCZ696 is Effective Across the Spectrum of Ejection Fraction in Heart Failure With Reduced Ejection Fraction
    Solomon, Scott
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean
    Letkowitz, Martin
    Shi, Victor
    Desai, Akshay
    Claggett, Brian
    Starling, Randall
    McMurray, John J. V.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S45 - S46
  • [7] Elevation in High-Sensitivity Troponin T in Heart Failure and Preserved Ejection Fraction and Influence of Treatment With the Angiotensin Receptor Neprilysin Inhibitor LCZ696
    Jhund, Pardeep S.
    Claggett, Brian L.
    Voors, Adriaan A.
    Zile, Michael R.
    Packer, Milton
    Pieske, Burkert M.
    Kraigher-Krainer, Elisabeth
    Shah, Amil M.
    Prescott, Margaret F.
    Shi, Victor
    Lefkowitz, Marty
    McMurray, John J. V.
    Solomon, Scott D.
    CIRCULATION-HEART FAILURE, 2014, 7 (06) : 953 - U129
  • [8] Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction
    Kobalava, Zhanna
    Kotovskaya, Yulia
    Averkov, Oleg
    Pavlikova, Elena
    Moiseev, Valentine
    Albrecht, Diego
    Chandra, Priya
    Ayalasomayajula, Surya
    Prescott, Margaret F.
    Pal, Parasar
    Langenickel, Thomas H.
    Jordaan, Pierre
    Rajman, Iris
    CARDIOVASCULAR THERAPEUTICS, 2016, 34 (04) : 191 - 198
  • [9] The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction: A Phase II Randomised-Controlled Trial
    Solomon, Scott D.
    Zile, Michael
    Pieske, Burken
    Voors, Adriaan A.
    Shah, Amil
    Kraigher-Krainer, Elisabeth
    Shi, Victor
    Bransford, Toni
    Takeuchi, Madoka
    Gong, Jianjian
    Lefkowitz, Martin
    Packer, Milton
    McMurray, John J. V.
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (11) : 883 - 883
  • [10] LCZ696 THERAPY IS ASSOCIATED WITH IMPROVEMENT OF VENTRICULAR ARTERIAL COUPLING AND WORK EFFICIENCY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION
    Kobalava, Z.
    Babaeva, L.
    Lukina, O.
    Zharikova, E.
    Tyukhmenev, E.
    Villevalde, S.
    JOURNAL OF HYPERTENSION, 2016, 34 : E239 - E239